Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6268)
All Articles published online
|
Publishing Process of This Article
|
Jun 7, 2014 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Na GH, Kim DG, Han JH, Kim EY, Lee SH, Hong TH, You YK. Inflammatory markers as selection criteria of hepatocellular carcinoma in living-donor liver transplantation. World J Gastroenterol 2014; 20(21): 6594-6601 [PMID: 24914382 DOI: 10.3748/wjg.v20.i21.6594] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i21/6594.htm |
| Number | Citing Articles |
| 1 |
Kazim Duman, Ali Harlak. Are endothelial damage and inflammation level demonstrated clearly in liver transplant patients?. Asian Journal of Surgery 2016; 39(3): 195 doi: 10.1016/j.asjsur.2016.01.004
|
| 2 |
Xiao-Dong Sun, Xiao-Ju Shi, Yu-Guo Chen, Chuan-Lei Wang, Qiang Ma, Guo-Yue Lv. Elevated Preoperative Neutrophil-Lymphocyte Ratio Is Associated with Poor Prognosis in Hepatocellular Carcinoma Patients Treated with Liver Transplantation: A Meta-Analysis. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/4743808
|
| 3 |
Xingshun Qi, Jianjun Li, Han Deng, Hongyu Li, Chunping Su, Xiaozhong Guo. Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studies. Oncotarget 2016; 7(29): 45283 doi: 10.18632/oncotarget.9942
|
| 4 |
Jae Hyun Yoon, Sung Kyu Choi. Management of early-stage hepatocellular carcinoma: challenges and strategies for optimal outcomes. Journal of Liver Cancer 2023; 23(2): 300 doi: 10.17998/jlc.2023.08.27
|
| 5 |
Arvinder S. Soin, Prashant Bhangui, Tejinder Kataria, Sanjay S. Baijal, Tarun Piplani, Dheeraj Gautam, Narendra S. Choudhary, Srinivasan Thiagarajan, Amit Rastogi, Neeraj Saraf, Sanjiv Saigal. Experience With LDLT in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis Postdownstaging. Transplantation 2020; 104(11): 2334 doi: 10.1097/TP.0000000000003162
|
| 6 |
Dong-Wei Xu, Ping Wan, Qiang Xia. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review. World Journal of Gastroenterology 2016; 22(12): 3325-3334 doi: 10.3748/wjg.v22.i12.3325
|
| 7 |
Tsuyoshi Shimamura, Ryoichi Goto, Masaaki Watanabe, Norio Kawamura, Yasutsugu Takada. Liver Transplantation for Hepatocellular Carcinoma: How Should We Improve the Thresholds?. Cancers 2022; 14(2): 419 doi: 10.3390/cancers14020419
|
| 8 |
Dongdong Zhou, Xiaoli Liu, Xinhui Wang, Fengna Yan, Peng Wang, Huiwen Yan, Yuyong Jiang, Zhiyun Yang. A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-07916-3
|
| 9 |
H.S. Chung, E.S. Kim, J.H. Park, C.S. Park. Prediction of Gross Post-Transplant Outcomes Based on the Intra-Operative Decline in C-Reactive Protein in Living Donor Liver Transplantation. Transplantation Proceedings 2015; 47(2): 431 doi: 10.1016/j.transproceed.2015.01.005
|
| 10 |
Arno Kornberg, Martina Schernhammer, Jennifer Kornberg, Helmut Friess, Katharina Thrum. Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma. Digestive Diseases and Sciences 2019; 64(1): 269 doi: 10.1007/s10620-018-5296-9
|
| 11 |
Mohamad Mouchli, Shravani Reddy, Miranda Gerrard, Lisa Boardman, Marrieth Rubio. Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma." Review article. Annals of Hepatology 2021; 22: 100249 doi: 10.1016/j.aohep.2020.08.067
|
| 12 |
Maria J Citores, Jose L Lucena, Sara de la Fuente, Valentin Cuervas-Mons. Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation. World Journal of Hepatology 2019; 11(1): 50-64 doi: 10.4254/wjh.v11.i1.50
|
| 13 |
Zheng-Guang Xu, Cheng-Jie Ye, Lin-Xun Liu, Gang Wu, Zhan-Xue Zhao, Yong-Zhen Wang, Bing-Qiang Shi, Yong-Hong Wang. The Pretransplant Neutrophil-Lymphocyte Ratio as a New Prognostic Predictor After Liver Transplantation For Hepatocellular Cancer: a Systematic Review and Meta-analysis. Biomarkers in Medicine 2018; 12(2): 189 doi: 10.2217/bmm-2017-0307
|
| 14 |
Nourhan Badwei, Waheed A. Monsef, Iman Montasser, Mohamed Bahaa, Mahmoud El Meteini, Shimaa Y. Kamel. Role of inflammatory markers in predicting hepatocellular carcinoma recurrence after liver transplantation. Egyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00105-8
|
| 15 |
Pil Soo Sung, Isaac Kise Lee, Pu Reun Roh, Min Woo Kang, Jaegyoon Ahn, Seung Kew Yoon. Blood-based biomarkers for immune-based therapy in advanced HCC: Promising but a long way to go. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1028728
|
| 16 |
Jiang Liu, Chung Mau Lo, Kwan Man. Role of Intrahepatic Regional Immunity in Post-Transplant Cancer Recurrence. Engineering 2022; 10: 57 doi: 10.1016/j.eng.2021.11.012
|
| 17 |
Naveen Ganjoo, Thomas D. Schiano. Disease Recurrence After Liver Transplantation. 2016; : 165 doi: 10.1007/978-1-4939-2947-4_12
|
| 18 |
Ilze Strumfa, Dzeina Mezale, Boriss Strumfs, Andrejs Vanags, Arturs Kalva, Dainis Balodis, Ilze Fridrihsone, Arnis Abolins, Janis Gardovskis. Hepatocellular Carcinoma - Advances in Diagnosis and Treatment. 2018; doi: 10.5772/intechopen.76599
|
| 19 |
Taizo Hibi, Osamu Itano, Masahiro Shinoda, Yuko Kitagawa. Liver transplantation for hepatobiliary malignancies: a new era of “Transplant Oncology” has begun. Surgery Today 2017; 47(4): 403 doi: 10.1007/s00595-016-1337-1
|
| 20 |
Tobias Meischl, Susanne Rasoul-Rockenschaub, Georg Györi, Wolfgang Sieghart, Thomas Reiberger, Michael Trauner, Thomas Soliman, Gabriela Berlakovich, Matthias Pinter, Matias A. Avila. C-reactive protein is an independent predictor for hepatocellular carcinoma recurrence after liver transplantation. PLOS ONE 2019; 14(5): e0216677 doi: 10.1371/journal.pone.0216677
|
| 21 |
Hae Won Lee, Kyung-Suk Suh. Expansion of the criteria for living donor liver transplantation for hepatocellular carcinoma. Current Opinion in Organ Transplantation 2016; 21(2): 231 doi: 10.1097/MOT.0000000000000294
|
| 22 |
Arno Kornberg, Ulrike Witt, Jennifer Kornberg, Katharina Müller, Helmut Friess, Katharina Thrum. Postoperative peak serum C-reactive protein is a predictor of outcome following liver transplantation for hepatocellular carcinoma. Biomarkers 2016; 21(2): 152 doi: 10.3109/1354750X.2015.1118548
|
| 23 |
Daniele Nicolini, Andrea Agostini, Roberto Montalti, Federico Mocchegiani, Cinzia Mincarelli, Alessandra Mandolesi, Nicola L Robertson, Roberto Candelari, Andrea Giovagnoni, Marco Vivarelli. Radiological response and inflammation scores predict tumour recurrence in patients treated with transarterial chemoembolization before liver transplantation. World Journal of Gastroenterology 2017; 23(20): 3690-3701 doi: 10.3748/wjg.v23.i20.3690
|
| 24 |
Sami Akbulut, Cemalettin Koc. Do We Need to Be Limited by Matching Milan Criteria for Survival in Living Donor Liver Transplantation?. Journal of Gastrointestinal Cancer 2020; 51(4): 1107 doi: 10.1007/s12029-020-00482-0
|
| 25 |
Guang‐Tao Min, Yu‐Min Li, Nan Yao, Jun Wang, Hong‐Peng Wang, Wei Chen. The pretreatment neutrophil‐lymphocyte ratio may predict prognosis of patients with liver cancer: A systematic review and meta‐analysis. Clinical Transplantation 2018; 32(1) doi: 10.1111/ctr.13151
|
| 26 |
Hyung Mook Lee, Taehee Kim, Ho Joong Choi, Jaesik Park, Jung-Woo Shim, Yong-Suk Kim, Young Eun Moon, Sang Hyun Hong, Min Suk Chae. Influence of intraoperative oxygen content on early postoperative graft dysfunction in living donor liver transplantation. Medicine 2020; 99(21): e20339 doi: 10.1097/MD.0000000000020339
|
| 27 |
Jan Lerut, Maxime Foguenne, Quirino Lai. Hepatocellular cancer selection systems and liver transplantation: from the tower of babel to an ideal comprehensive score. Updates in Surgery 2021; 73(5): 1599 doi: 10.1007/s13304-021-01078-4
|
| 28 |
Kuang-Den Chen, Chien-Ning Hsu, Yi-Ju Wu, Chi-Hsiang Chu, Kuang-Tzu Huang, Ming-Chao Tsai, King-Wah Chiu, Ben-Chung Cheng, Chien-Hua Chiu, Chao-Long Chen, Chih-Che Lin. The Perioperatively Altered Neutrophil-to-Lymphocyte Ratio Associates with Impaired DNA Damage Response in Liver Transplantation Recipients with Hepatocellular Carcinoma. Diagnostics 2021; 11(2): 209 doi: 10.3390/diagnostics11020209
|
| 29 |
Prithiviraj Nabi, Ashwin Rammohan, Mohamed Rela. Living Donor Liver Transplantation for Hepatocellular Carcinoma. Journal of Clinical and Experimental Hepatology 2024; 14(6): 101933 doi: 10.1016/j.jceh.2024.101933
|